Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
US7160893B2 · kind B2 · utility
11Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2003 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Jun 16, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides compounds defined by Formula Ior a pharmaceutically acceptable salt thereof,wherein R1, Q, R2, R3, and R4 are as defined in the specification. The invention also provides related pharmaceutical compositions, methods of use, and combinations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.